Exodus Point Capital Management, LP Delcath Systems, Inc. Transaction History
Exodus Point Capital Management, LP
- $10.1 Billion
- Q1 2025
A detailed history of Exodus Point Capital Management, LP transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 699,352 shares of DCTH stock, worth $12 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
699,352
Previous 51,697
1252.79%
Holding current value
$12 Million
Previous $622,000
1331.35%
% of portfolio
0.09%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DCTH
# of Institutions
104Shares Held
12.1MCall Options Held
79KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.39MShares$23.8 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$13.9 Million0.26% of portfolio
-
Vivo Capital, LLC Palo Alto, CA750KShares$12.8 Million2.59% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA557KShares$9.53 Million0.0% of portfolio
-
Gilder Gagnon Howe & CO LLC New York, NY539KShares$9.21 Million0.1% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $147M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...